Abstract
Over the last 20 years, there has been a steady and consistent reduction in mortality for pediatric cardiac surgery. This improvement has occurred in spite of an increase in complexity of cases undertaken as well as a shift to surgery in infants and neonates. At many major pediatric cardiac surgery centers such as Children’s National Medical Center in Washington DC, approximately 30% of cardiac surgical patients today are neonates, 30% are infants between 1 month and 1 year of age, and the remaining are older. Even conditions such as hypoplastic left heart syndrome can now be palliated in the newborn period applying the Norwood procedure with a mortality as low as 10-15%.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Turley K, Roizen M, Ebert PA. Deep hypothermia and total circulatory arrest: the effect of method of cooling on the catecholamine response to arrest. J Surg Res. 1981;30(4):379-383.
Jonas RA, Newburger JW, Volpe JJ (eds) Brain Injury and Pediatric Cardiac Surgery. Butterworth-Heinemann, 1995
Newburger JW, Jonas RA, Wernovsky G, et al. A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low flow cardiopulmonary bypass in infant heart surgery. N Engl J Med. 1993;329:1057-1064.
Goldberg CS, Bove EL, Devaney EJ, et al. A randomized clinical trial of regional cerebral perfusion versus deep hypothermic circulatory arrest: outcomes for infants with functional single ventricle. J Thorac Cardiovasc Surg. 2007; 133(4):880-887.
Duebener LF, Hagino I, Schmitt K, et al. Direct visualization of minimal cerebral capillary flow during retrograde cerebral perfusion: an intravital fluorescence microscopy study in pigs. Ann Thorac Surg. 2003;75(4):1288-1293.
McQuillen PS, Barkovich AJ, Hamrick SE, et al. Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke. 2007;38(2 Suppl):736-741.
Rahn H, Reeves RB, Howell BJ. Hydrogen ion regulation, temperature, and evolution. Am Rev Respir Dis. 1975;112(2):165-172.
Wong PC, Barlow CF, Hickey PR, et al. Factors associated with choreoathetosis after cardiopulmonary bypass in children with congenital heart disease. Circulation. 1992;86(II):II–118-126.
Jonas RA, Bellinger DC, Rappaport LA, et al. Relation of pH strategy and developmental outcome after hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1993;106(2):362-368.
Aoki M, Nomura F, Stromski ME, et al. Effects of pH on brain energetics after hypothermic circulatory arrest. Ann Thorac Surg. 1993;55(5):1093-1103.
Hiramatsu T, Miura T, Forbess JM, et al. pH strategies and cerebral energetics before and after circulatory arrest. J Thorac Cardiovasc Surg. 1995;109(5):948-957.
du Plessis AJ, Jonas RA, Wypij D, et al. Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 1997;114(6):991-1000.
Bellinger DC, Wypij D, du Plessis AJ, et al. Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 2001;121(2):374-383.
Cook DJ, Orszulak TA, Daly RC, MacVeigh I. Minimum hematocrit for normothermic cardiopulmonary bypass in dogs. Circulation. 1997;96((9):II–200-4.
Shin’oka T, Shum-Tim D, Jonas RA, et al. Higher hematocrit improves cerebral outcome after deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1996;112(6):1610-1620.
Shin’oka T, Shum-Tim D, Laussen PC, et al. Effects of oncotic pressure and hematocrit on outcome after hypothermic circulatory arrest. Ann Thorac Surg. 1998;65(1):155-164.
Visconti KJ, Bichell DP, Jonas RA, Newburger JW, Bellinger DC. Developmental outcome after surgical versus interventional closure of secundum atrial septal defect in children. Circulation. 1999;100(19):II145-50.
Jonas RA, Wypij D, Roth SJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg. 2003;126(6):1765-1774.
Newburger JW, Jonas RA, Soul J, et al. Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac Cardiovasc Surg. 2008;135(2):347-354. 354.
Wypij D, Jonas RA, Bellinger DC, et al. The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg. 2008;135(2):355-360.
Sakamoto T, Hatsuoka S, Stock UA, et al. Prediction of safe duration of hypothermic circulatory arrest by near-infrared spectroscopy. J Thorac Cardiovasc Surg. 2001;122(2):339-350.
Sakamoto T, Zurakowski D, Duebener LF, et al. Interaction of temperature with hematocrit level and pH determines safe duration of hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2004;128(2):220-232.
Sakamoto T, Zurakowski D, Duebener LF, et al. Combination of alpha-stat strategy and hemodilution exacerbates neurologic injury in a survival piglet model with deep hypothermic circulatory arrest. Ann Thorac Surg. 2002;73(1):180-189.
Anttila V, Hagino I, Zurakowski D, et al. Specific bypass conditions determine safe minimum flow rate. Ann Thorac Surg. 2005;80(4):1460-1467.
Hagino I, Anttila V, Zurakowski D, Duebener LF, Lidov HG, Jonas RA. Tissue oxygenation index is a useful monitor of histologic and neurologic outcome after cardiopulmonary bypass in piglets. J Thorac Cardiovasc Surg. 2005;130(2):384-392.
Anttila V, Christou H, Hagino I, et al. Cerebral endothelial nitric oxide synthase expression is reduced after very-low-flow bypass. Ann Thorac Surg. 2006 Jun;81(6):2202-2206.
Nicole O, Docagne F, Ali C, et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 2001;7(1):59-64.
Mangano DT, Rieves RD, Weiss KD. Judging the safety of aprotinin. N Engl J Med. 2006;355(21):2261-2262.
Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004;128(3):442-448.
Fergusson DA, Hébert PC, Mazer CD, et al. the BART Investigators. A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery. N Engl J Med. 2008;358:2319-2331.
Aoki M, Jonas RA, Nomura F, et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg. 1994;58(1):146-153.
Lebeurrier N, Liot G, Lopez-Atalaya JP, et al. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo. Mol Cell Neurosci. 2005;30(4):552-558.
Cinelli P, Madani R, Tsuzuki N, et al. Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol Cell Neurosci. 2001;18:443-457.
Iwata Y, Nicole O, Okamura T, Zurakowski D, Jonas RA. Aprotinin confers neuroprotection by reducing excitotoxic cell death. J Thorac Cardiovasc Surg. 2008;135(3):573-578.
Anttila V, Hagino I, Iwata Y, et al. Aprotinin improves cerebral protection: evidence from a survival porcine model. J Thorac Cardiovasc Surg. 2006;132(4):948-953.
Iwata Y, Okamura T, Ishibashi N, Zurakowski D, Lidov HGW, Jonas RA. Optimal dose of aprotinin for neuroprotection and renal function in a piglet survival model. J Thorac Cardiovasc Surg, submitted.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer London
About this chapter
Cite this chapter
Jonas, R.A. (2011). Experimental Basis and Clinical Studies of Brain Protection in Pediatric Heart Surgery. In: Bonser, R., Pagano, D., Haverich, A. (eds) Brain Protection in Cardiac Surgery. Springer, London. https://doi.org/10.1007/978-1-84996-293-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-84996-293-3_17
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84996-292-6
Online ISBN: 978-1-84996-293-3
eBook Packages: MedicineMedicine (R0)